Merck today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients […]

Wageningen, Netherlands; San Carlos, CA, USA Today NuGEN Technologies, Inc. and Keygene N.V. announced an agreement to settle a declaratory judgment lawsuit brought by NuGEN Technologies concerning KeyGene’s U.S. Patent Nos. 9,702,004, 9,745,627 and 9,896,721. Under the terms of the settlement, the lawsuit and counterclaims have been dismissed. Financial terms and other specifics of the settlement were […]

Cambridge, UK Fluidic Analytics Ltd, has announced the issuance of US Patent 9,952,22 B2, entitled ‘Fluidic Separation and Detection’, from the United States Patent and Trademark Office. This paves the way for the development and commercialisation of a next-generation protein analysis technology platform to be launched later this year. “The issuance of the US Patent […]

Mountain View, CA—Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that patent JP6336080B—covering the Smart-seq2 method, developed by Rickard Sandberg and exclusively licensed to TBUSA by the Ludwig Institute—has been awarded by the Japan Patent Office. Additional patents regarding the Smart-seq2 technology […]

WINOOSKI VT, USA — BioTek Instruments, Inc., a leader in life science instrumentation, was issued a patent by the United States Patent and Trademark Office for its “User-Trained Autofocus” feature in their Gen5™ Microplate Reader and Imager Software, integrated with their advanced cell imaging systems. This autofocus method allows users to overcome imaging challenges arising […]

New data shows Inscripta’s MADzymes edit in mammalian cells Boulder, Colo. – Inscripta, a leading gene-editing technology company, today announced two significant milestones. First, the USPTO granted Inscripta its first patent covering systems using MAD7, the company’s first free CRISPR enzyme, as well as patent coverage for systems using another MADzyme, MAD2. Second, Inscripta released new […]

Dublin/Ireland – ERS Genomics announced today that the U.S. Patent and Trademark Office (USPTO) has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, their first U.S. patent with claims covering the use of CRISPR/Cas9 technology for gene editing. The patent covers the use of an optimized guide […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore will refrain from offering “2D” sequencing products through the end […]

Merck today announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. DARMSTADT, GERMANY Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells Company to license CRISPR-related patents to interested parties, […]

Agilent Technologies Inc (NYSE:A) has filed a civil lawsuit against Changzhou Pannatek Co., Ltd. (“Pannatek”), and a former employee of Agilent, alleging infringement of trade secrets, copyright of computer software, and petitioning the court to stop the defendants’ use of Agilent’s proprietary technologies. This follows the civil lawsuit Agilent filed last year against Shanghai Echrom […]